One
key limitation of the recent Fitbit study, says Dr. Vincent Thijs, an expert on
stroke at the University of Melbourne's Florey Institute of Neuroscience and Mental Health, is that it demonstrates only that the tracker and algorithm can detect persistent or permanent atrial fibrillation, rather than paroxysmal AFib (or
short, sudden spasms).